HOME >> BIOLOGY >> NEWS
Pitt Professor awarded competitive Sloan Research Fellowship

PITTSBURGH--Marc Sommer, assistant professor in the University of Pittsburgh's Department of Neuroscience, has received an Alfred P. Sloan Research Fellowship, a competitive award given to the "very best" scientists at an early stage in their faculty careers.

The two-year, $45,000 award will fund Sommer's research into how brain areas communicate with each other during normal behaviors, and how this communication breaks down in such mental disorders as schizophrenia. Sommer studies the signals sent from deep brain structures, such as the cerebellum, to the prefrontal cortex, considered to be the seat of cognitive abilities.

Sommer is investigating how this input to prefrontal cortex normally influences how we see, move, and make decisions, and how the flow of information is altered in an animal model of schizophrenia. To do this, he "eavesdrops" on single nerve cells using fine electrodes with microscopic tips, and also determines the inputs and outputs of the cells.

"Marc's approach, the creativity he brings to what he does, is quite unusual for a starting-out scientist," said Alan Sved, chair of Pitt's neuroscience department. "There's no question in my mind and those of the faculty in the department that Marc is the most outstanding young scientist now working in the area of sensorimotor processing in primate cortex."

The Alfred P. Sloan Foundation, a philanthropic nonprofit institution, was established in 1934 by Alfred Pritchard Sloan Jr., then-president and chief executive officer of the General Motors Corporation. The Sloan Research Fellowships were established in 1955 to provide support and recognition to early-career scientists and scholars, often in their first appointments to university faculties, who were endeavoring to set up laboratories and establish their independent research projects with little or no outside support. Currently, a total of 116 fellowships are awarded annually in seven fields: chemistry, computational
'"/>

Contact: Karen Hoffmann
klh52@pitt.edu
412-624-4356
University of Pittsburgh
5-May-2005


Page: 1 2

Related biology news :

1. UCSB Assistant Professor Patrick Daugherty wins Young Investigator Award from ACS
2. Krber Prize to ETH Zurich Professor Seeberger
3. Professors to develop hand-held pathogen testing device
4. Professor analyzes nuclear receptors in bee genome
5. Professor earns carbon sequestration research grant
6. Tufts David Walt named Howard Hughes Medical Institute Professor
7. Richard Zare named Howard Hughes Medical Institute Professor
8. Stevens Professor Alan Blumberg to speak at New York Public Library
9. Yale Public Health Professor elected fellow of the American Statistical Association
10. Allergies affect 15 million people in UK, says Professor
11. Jan Lwe awarded 2007 EMBO Gold Medal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pitt Professor awarded competitive Sloan Research Fellowship

(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: